PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC13231543::ACT047729

sP10

Evidence text

Paper-level observation

Further analysis of mouse lung surface metastases (Supplementary Fig. S4G) and IHC staining of lung tissue sections (Fig. 3H) revealed that sP10 significantly decreased the number of lung metastases.
figureConfidence: medium

Assay observation

Activity
Anticancer
Subtype
Not reported by source
Measure
qualitative
Comparator
=
Raw observation
significantly decreased the number of lung metastases
Normalized measurement
=0
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Not reported by source
Assay method
Not reported by source
Sequence
YGRKKRRQRRRCGPVWFLIFSYFLFFSISLARGPC
Standardization
ready simple

Source publication

Peptide aptamer sP10 targeting NPM1 attenuates liver fibrosis and hepatocellular carcinoma.

Journal of Translational Medicine · 2026

DOI 10.1186/s12967-026-08144-8 PMC13231543
Parent mention

Related peptide identities

PEPDIA-PLP-003251

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.